Exam 9: Principles for Competitive-Binding Assays
Exam 1: Basic Laboratory Principles and Techniques20 Questions
Exam 2: Spectral Techniques20 Questions
Exam 3: Chromatography and Mass Spectrometry: Theory, Practice, and Instrumentation20 Questions
Exam 4: Chromatographic Techniques20 Questions
Exam 5: Laboratory Analysis of Hemoglobin Variants20 Questions
Exam 6: Electrophoresis20 Questions
Exam 7: Immunological Reactions20 Questions
Exam 8: Immunochemical Techniques20 Questions
Exam 9: Principles for Competitive-Binding Assays20 Questions
Exam 10: Laboratory Approaches to Serology Testing20 Questions
Exam 11: Measurement of Colligative Properties17 Questions
Exam 12: Electrochemistry: Principles and Measurement17 Questions
Exam 13: Molecular Diagnostics17 Questions
Exam 14: Therapeutic Drug Monitoring17 Questions
Exam 15: Clinical Enzymology17 Questions
Exam 16: Protein Isoforms: Isoenzymes and Isoforms17 Questions
Exam 17: Interferences in Chemical Analysis17 Questions
Exam 18: Sources and Control of Preanalytical Variation17 Questions
Exam 19: Laboratory Management17 Questions
Exam 20: Laboratory Automation17 Questions
Exam 21: Point-Of-Care Near-Patient Testing17 Questions
Exam 22: Laboratory Information Systems17 Questions
Exam 23: Laboratory Statistics17 Questions
Exam 24: Reference Intervals and Clinical Decision Limits16 Questions
Exam 25: Quality Control for the Clinical Chemistry Laboratory16 Questions
Exam 26: Evaluation of Methods17 Questions
Exam 27: Classification and Description of Proteins, Lipids, and Carbohydrates16 Questions
Exam 28: Physiology and Pathophysiology of Body Water and Electrolytes17 Questions
Exam 29: Acid-Base Control and Acid-Base Disorders16 Questions
Exam 30: Renal Function17 Questions
Exam 31: Liver Function17 Questions
Exam 32: Diagnosis of Viral Hepatitis17 Questions
Exam 33: Bone Disease17 Questions
Exam 34: The Pancreas: Function and Chemical Pathology17 Questions
Exam 35: Gastrointestinal Function17 Questions
Exam 36: Cardiac and Muscle Disease17 Questions
Exam 37: Coronary Artery Disease: Lipid Metabolism17 Questions
Exam 38: Diabetes Mellitus17 Questions
Exam 39: Iron and Porphyrin Metabolism18 Questions
Exam 40: Hemoglobin18 Questions
Exam 41: Human Nutrition18 Questions
Exam 42: Trace Metals18 Questions
Exam 43: Vitamins18 Questions
Exam 44: Pregnancy and Fetal Development18 Questions
Exam 45: The Newborn18 Questions
Exam 46: Extravascular Biological Fluids18 Questions
Exam 47: Nervous System18 Questions
Exam 48: General Endocrinology18 Questions
Exam 49: Thyroid18 Questions
Exam 50: The Gonads18 Questions
Exam 51: Adrenal Hormones and Hypertension18 Questions
Exam 52: Diseases of Genetic Origin18 Questions
Exam 53: Neoplasia18 Questions
Exam 54: Laboratory Evaluation of the Transplant Recipient18 Questions
Exam 55: Toxicology18 Questions
Exam 56: Addiction and Substance Abuse18 Questions
Select questions type
As a preliminary step before performing the assay, some competitive-binding assays either adjust the pH of the patient sample or add an excess of a ligand that is similar to that being measured.Which of the following correctly describes the purpose for these preliminary steps?
Free
(Multiple Choice)
4.8/5
(43)
Correct Answer:
A
The advantage of using europium chelates, as compared to fluorescein, in time-resolved fluorescence competitive-binding assays is:
Free
(Multiple Choice)
4.9/5
(34)
Correct Answer:
D
In a competitive-binding heterogeneous assay, the captive phase involves:
Free
(Multiple Choice)
4.7/5
(32)
Correct Answer:
B
In ____________ competitive-binding assays, paramagnetic particles are used to capture and concentrate bound label on the surface of an electrode.
(Multiple Choice)
4.8/5
(36)
Which of the following are the two most important characteristics of the fluorophore utilized as the label in fluorescence immunoassays?
(Multiple Choice)
4.9/5
(29)
What is the purpose of the "label" used in competitive-binding assays?
(Multiple Choice)
4.8/5
(27)
ELISA is considered a ______ assay, and EMIT is considered a ______ assay.______ assay would be considered more suitable for automated chemistry analyzers.
(Multiple Choice)
4.9/5
(43)
_______ measures the decrease of incident light transmission as a function of light scatter as the size of the aggregated particles increase, and the use of a ________ detection system increases the analytical sensitivity of these measurements.
(Multiple Choice)
4.9/5
(41)
Competitive-binding assays that require the antibody-bound, labeled ligand be physically separated from the free labeled ligand are called ________ techniques.Those techniques that do not require physical separation are called _______ techniques, and these assays require _______.
(Multiple Choice)
4.8/5
(29)
All of the following are important aspects of competitive-binding assays except:
(Multiple Choice)
4.9/5
(36)
In microparticle-based light-scattering inhibition immunoassays, as concentration of measured ligand in the patient sample increases, the amount of light scattered in nephelometric measurements ______, and the absorbance reading in turbidimetric measurements ______.
(Multiple Choice)
4.9/5
(37)
In the fluorescence polarization immunoassay (FPIA) technique, the amount of polarized fluorescent light detected when the fluorophore is excited with polarized light is higher for:
(Multiple Choice)
4.9/5
(37)
Which of the following best describes the effect of nonspecific binding on the detection limit of an immunoassay?
(Multiple Choice)
4.7/5
(34)
Which of the following labels is attached to the ligand in the EMIT system?
(Multiple Choice)
4.7/5
(33)
Suppose your laboratory uses the ELISA configuration in which the antibody has been immobilized onto the solid phase.How would the result of the assay for a patient whose specimen is in a specific well be affected by improperly washing the solid phase of that particular well?
(Multiple Choice)
4.9/5
(40)
Which of the following data-reduction methods would convert a curved relationship for competitive protein-binding, dose-response relationships to a linear relationship?
(Multiple Choice)
4.9/5
(34)
In the EMIT system, the absorbance of the product is ______ proportional to the concentration of the unlabeled ligand in the reaction.In the FPIA system, the amount of polarized fluorescent light produced by the reaction is ______ proportional to the concentration of the unlabeled ligand in the reaction.
(Multiple Choice)
4.8/5
(31)
In competitive-binding assays, the relationship between concentration of unlabeled ligand and percent labeled ligand bound can be described in which of the following ways?
(Multiple Choice)
4.8/5
(38)
Which of the following approaches to competitive-binding immunoassays would be most likely to improve the sensitivity of the assay for a specific ligand?
(Multiple Choice)
4.8/5
(45)
Filters
- Essay(0)
- Multiple Choice(0)
- Short Answer(0)
- True False(0)
- Matching(0)